LSIPR 50 2016: Martin Shkreli and Jim Tananbaum


Martin Shkreli and Jim Tananbaum were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Shkreli and Tananbaum were featured in the investment section, as LSIPR reports.


Name: Martin Shkreli

Organisation: Formerly of Turing Pharmaceuticals

Martin Shkreli, Jim Tananbaum, Turing Pharmaceuticals, drugs, Foresite Capital, Jazz Pharmaceuticals,